Delisting riskPopularity #3,538
PDS Biotechnology (PDSB)
Develops investigational immunotherapies for cancer and infectious diseases.
$0.8474
vs last close−0.06 (−6.88%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 13.74% | 7.69M shares | |
|---|---|---|---|
| 53 holders · as of Jun 30, 2026 | |||
| Insiders | 23.49% | 13.15M shares | |
| 4 holders · as of Sep 21, 2026 | |||
| Other | 62.77% | 35.13M shares | |
| remainder | |||
55.97M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
53 holders · 7.69M shares · 14 new positions · 27 increased · 7 reduced · 4 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 1.70M | 3.04% | +68.2K | Aug 13, 2026 |
| Quantinno Capital Management LP | 642.2K | 1.15% | +642.2Knew | Aug 13, 2026 |
| Colony Group, LLC | 642.2K | 1.15% | +642.2Knew | Aug 12, 2026 |
| BlackRock, Inc. | 607.6K | 1.09% | +53.6K | Aug 7, 2026 |
| Geode Capital Management, LLC | 587.1K | 1.05% | −73.1K | Aug 12, 2026 |
| Vanguard Fiduciary Trust Co | 357.1K | 0.64% | +49.8K | Aug 13, 2026 |
| Militia Capital Management LLC | 331.8K | 0.59% | +331.8Knew | Aug 12, 2026 |
| Citadel Advisors LLC | 323.8K | 0.58% | +323.8Knew | Sep 2, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Nant Capital, LLCincl. Patrick Soon-Shiong | 19.90% | 20.34M | 13D | Sep 21, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.